Role of Bcl-2 family members in invertebrates

被引:40
|
作者
Igaki, T [1 ]
Miura, M [1 ]
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Bunkyo Ku, Tokyo 1130033, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2004年 / 1644卷 / 2-3期
关键词
Bcl-2; family; Caenorhabditis elegans; Drosophila; mitochondrion; cell death; apoptosis;
D O I
10.1016/j.bbamcr.2003.09.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteins belonging to the Bcl-2 family function as regulators of 'life-or-death' decisions in response to various intrinsic and extrinsic stimuli. In mammals, cell death is controlled by pro- and anti-apoptotic members of the Bcl-2 family, which function upstream of the caspase cascade. Structural and functional homologues of the Bcl-2 family proteins also exist in lower eukaryotes, such as nematodes and flies. In nematodes, an anti-apoptotic Bcl-2 family protein, CED-9, functions as a potent cell death inhibitor, and a BH3-only protein, EGL-1, acts as an inhibitor of CED-9 to facilitate the spatio-temporal regulation of programmed cell death. On the other hand, the Drosophila genome encodes two Bcl-2 family proteins, Drob-1/Debcl/dBorg-1/dBok and Buffy/dBorg-2, both of which structurally belong to the pro-apoptotic group, despite abundant similarities in the cell death mechanisms between flies and vertebrates. Drob-1 acts as a pro-apoptotic factor in vitro and in vivo, and Buffy/dBorg-2 exhibits a weak anti-apoptotic function. The ancestral role of the Bcl-2 family protein may be pro-apoptotic, and the evolution of the functions of this family of proteins may be closely linked with the contribution of mitochondria to the cell death pathway. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:73 / 81
页数:9
相关论文
共 50 条
  • [31] The Bcl-2 protein family and its role in the development of neoplastic disease
    Heiser, D
    Labi, V
    Erlacher, M
    Villunger, A
    EXPERIMENTAL GERONTOLOGY, 2004, 39 (08) : 1125 - 1135
  • [32] Differential interactions between Beclin 1 and bcl-2 family members
    Erlich, Shlomit
    Mizrachy, Liat
    Segev, Oshik
    Lindenboim, Liora
    Zmira, Ofir
    Adi-Harel, Sheli
    Hirsch, Joel A.
    Stein, Reuven
    Pinkas-Kramarski, Ronit
    AUTOPHAGY, 2007, 3 (06) : 561 - 568
  • [33] Bcl-2 family proteins and mitochondria
    Reed, JC
    Jurgensmeier, JM
    Matsuyama, S
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1366 (1-2): : 127 - 137
  • [34] Bcl-2 family proteins and apoptosis
    Fu, YF
    Fan, TJ
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2002, 34 (04): : 389 - 394
  • [35] Development of a flow cytometric method for quantification of BCL-2 family members in chronic lymphocytic leukemia and correlation with sensitivity to BCL-2 family inhibitors
    Smith, Morey L.
    Chyla, Brenda
    McKeegan, Evelyn
    Tahir, Stephen K.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2017, 92 (05) : 331 - 339
  • [36] Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells
    Zhou, Jing
    Zhang, Siyuan
    Ong, Choon-Nam
    Shen, Han-Ming
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (02) : 132 - 144
  • [37] Involvement of proapoptotic Bcl-2 family members in parthenolide-induced mitochondrial dysfunction and apoptosis
    Zhang, SY
    Ong, CN
    Shen, HM
    CANCER LETTERS, 2004, 211 (02) : 175 - 188
  • [38] Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines
    Selzer, E
    Schlagbauer-Wadl, H
    Okamoto, I
    Pehamberger, H
    Potter, R
    Jansen, B
    MELANOMA RESEARCH, 1998, 8 (03) : 197 - 203
  • [39] 2-Deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines
    Zagorodna, O.
    Martin, S. M.
    Rutkowski, D. T.
    Kuwana, T.
    Spitz, D. R.
    Knudson, C. M.
    ONCOGENE, 2012, 31 (22) : 2738 - 2749
  • [40] 2-Deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines
    O Zagorodna
    S M Martin
    D T Rutkowski
    T Kuwana
    D R Spitz
    C M Knudson
    Oncogene, 2012, 31 : 2738 - 2749